Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-08-13

Clinical Trial Update: Study Comparing ABVD vs BEACOPP in Advanced Hodgkin's Lymphoma [Phase 3]

View source ↗

Summary

This Phase 3 trial comparing ABVD versus BEACOPP regimens in advanced Hodgkin lymphoma has completed. The update notes the study status as completed, but the sn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bleomycin (bleomycin)
  • CYCLOPHOSPHAMIDE (Cyclophosphamide)
  • Dacarbazine (dacarbazine)
  • Doxorubicin (doxorubicin)
  • Etoposide (Etoposide)
  • PREDNISONE (Prednisone)
  • Procarbaz ine (Procarbazine)
  • Vinblastine (vinblastine)
  • Vincristine (vincristine)

Snippet

Sponsor: Fondazione Michelangelo | Conditions: Hodgkin Lymphoma | Phase 3 | Status: COMPLETED